4‐protein signature predicting tamoxifen treatment outcome in recurrent breast cancer

Estrogen receptor (ER) positive tumors represent the majority of breast malignancies, and are effectively treated with hormonal therapies, such as tamoxifen. However, in the recurrent disease resistance to tamoxifen therapy is common and a major cause of death. In recent years, in‐depth proteome ana...

Descripción completa

Detalles Bibliográficos
Autores principales: De Marchi, Tommaso, Liu, Ning Qing, Stingl, Cristoph, Timmermans, Mieke A., Smid, Marcel, Look, Maxime P., Tjoa, Mila, Braakman, Rene B.H., Opdam, Mark, Linn, Sabine C., Sweep, Fred C.G.J., Span, Paul N., Kliffen, Mike, Luider, Theo M., Foekens, John A., Martens, John W.M., Umar, Arzu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528925/
https://www.ncbi.nlm.nih.gov/pubmed/26285647
http://dx.doi.org/10.1016/j.molonc.2015.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528925/
https://www.ncbi.nlm.nih.gov/pubmed/26285647
http://dx.doi.org/10.1016/j.molonc.2015.07.004

Ejemplares similares